000			02105na a2200265 4500
003			PC5339
005			20180417112606.0
008			130622s2013 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aspa
100			_9560 _aAbradelo de Usera, Manuel _eCirugía General y Aparato Digestivo
100			_9358 _aJiménez Romero, Carlos _eCirugía General y del Aparato Digestivo
100			_9558 _aLoinaz Segurola, Carmelo _eCirugía General y del Aparato Digestivo
100			_9510 _aMoreno González, Enrique _eCirugía General y del Aparato Digestivo
245	0	0	_aTrasplante hepático con injerto procedente de donación después de muerte cardiocirculatoria controlada. Situacion actual. _h[artículo]
260			_bCirugía española, _c2013
300			_a91(9):554-62.
500			_aFormato Vancouver: Abradelo De Usera M, Jiménez Romero C, Loinaz Segurola C, Moreno González E. Trasplante hepático con injerto procedente de donación después de muerte cardiocirculatoria controlada. Situacion actual. Cir Esp. 2013 Nov;91(9):554-62.
501			_aPMID: 24021972
504			_aContiene 58 referencias
520			_aAn increasing pressure on the liver transplant waiting list, forces us to explore new sources, in order to expand the donor pool. One of the most interesting and with a promising potential, is donation after cardiac death (DCD). Initially, this activity has developed in Spain by means of the Maastricht type II donation in the uncontrolled setting. For different reasons, donation after controlled cardiac death has been reconsidered in our country. The most outstanding circumstance involved in DCD donation is a potential ischemic stress, that could cause severe liver graft cell damage, resulting in an adverse effect on liver transplant results, in terms of complications and outcomes. The complex and particular issues related to DCD Donation will be discussed in this review.
710			_9271 _aServicio de Cirugía General y del Aparato Digestivo
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/5/pc5339.pdf _ySolicitar documento
942			_n0 _2ddc _cART
999			_c5339 _d5339